# FDA Inspection 1233993 - Merck KGaA - July 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/merck-kgaa/b4911050-d784-40ae-8305-98f4c06a9345
Source feed: FDA_Inspections

> FDA Inspection 1233993 for Merck KGaA on July 19, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233993
- Company Name: Merck KGaA
- Inspection Date: 2024-07-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1241023 - 2023-10-06](https://www.keypedia.com/records/fda_inspections/merck-kgaa/5f02914e-4266-43fe-9c7d-5814a3ee6c40)
- [FDA Inspection 1029948 - 2017-09-08](https://www.keypedia.com/records/fda_inspections/merck-kgaa/6cc0f417-d04a-4832-8815-a53be8e4fb75)
- [FDA Inspection 1029948 - 2017-09-08](https://www.keypedia.com/records/fda_inspections/merck-kgaa/1ebb03c7-356a-4abf-9604-5b880656b035)
- [FDA Inspection 867759 - 2014-02-27](https://www.keypedia.com/records/fda_inspections/merck-kgaa/358cb71a-98e1-4dec-8a9e-be82221ff4a0)
- [FDA Inspection 653955 - 2010-02-10](https://www.keypedia.com/records/fda_inspections/merck-kgaa/33bc8741-9271-4f87-92b1-75ad36c18cd1)

Company: https://www.keypedia.com/companies/merck-kgaa/b5abb295-f221-4b66-9a49-d564f70c388b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d